SCHEMBL7701291

SCHEMBL7701291

CCCCC(NC(=O)c1ccccc1Oc1ccc(N2CCCC2)cc1)C(=O)CNS(=O)(=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 2/20 0.41
MAPT P10636 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
AHR P35869 1/20 0.39
GAA P10253 2/20 0.39
LMNA P02545 3/20 0.37
TP53 P04637 3/20 0.37
KMT2A Q03164 3/20 0.37
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 2/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CASP1 P29466 1/20 0.37
PKM P14618 1/20 0.37
ADAMTS4 O75173 1/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP13 P45452 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7675029 0.89 L3MBTL1 (0.44) MAPTRAB9ALMNAKMT2AALDH1A1
SCHEMBL7421842 0.80 L3MBTL1 (0.46) MAPTRAB9AGAALMNAKMT2A
SCHEMBL7599622 0.78 CAPN1 (0.33) GFERMAPTSMN1; SMN2GAALMNA
SCHEMBL7428250 0.77 KCNA5 (0.44) GAAKMT2AMEN1CASP1MMP1
SCHEMBL7701336 0.76 CASP1 (0.49) MAPTGAAKMT2AALDH1A1MEN1
SCHEMBL7564537 0.75 CA2 (0.54) NPC1RAB9AGAALMNAALDH1A1
SCHEMBL7659831 0.74 KDM4E (0.48) MAPTRAB9AGAALMNAKMT2A
SCHEMBL7690197 0.73 CAPN1 (0.51) SMN1; SMN2LMNAKMT2AALDH1A1MEN1
SCHEMBL7666903 0.73 KDM4E (0.47) MAPTSMN1; SMN2RAB9AGAALMNA
SCHEMBL7695233 0.73 CAPN1 (0.54) CASP1MMP1MMP2MMP13MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed